Hamilton Thorne
Beverly, US · Ontario, Canada corporation
Founders & leadership
DW
David WolfExecutive
DH
Diarmaid H. Douglas-HamiltonNamed on SEC filing
DT
Daniel ThorneNamed on SEC filing
Board
MS
Meg SpencerBoard director
DG
Dean GendronBoard director
BM
Bruno MaruzzoBoard director
MB
Michael BrunsBoard director
RP
Robert PotterBoard director
Reported raises · per SEC filings
Form D private placements$11.2M disclosed across 4 rounds · 2014–2017
▶$150KraisedOct 2017 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedOct 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WolfExecutive Officer, Director
- Daniel ThorneDirector
- David SableDirector
- Bruno MaruzzoDirector
- Meg SpencerDirector
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Dean GendronDirector
- Michael BrunsExecutive Officer
- Robert PotterDirector
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Sep 2017
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$9.2MraisedMay 2017 · 21 investors · BiotechnologyRule 506(b)
▶$9.2MraisedMay 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SableDirector
- Daniel ThorneDirector
- Dean GendronDirector
- Michael BrunsExecutive Officer
- Robert PotterDirector
- Meg SpencerDirector
- Bruno MaruzzoDirector
- David WolfExecutive Officer, Director
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- Sales commissions
- $426.9K
- First sale
- Apr 2017
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$1.2MraisedJun 2015 · 17 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJun 2015 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Diarmaid H. Douglas-HamiltonDirector
- Meg SpencerDirector
- Dean GendronDirector
- David WolfExecutive Officer, Director
- Bruno MaruzzoDirector
- Michael BrunsDirector
- Robert PotterDirector
- Daniel ThorneDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jun 2015
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$660.7KraisedNov 2014 · 16 investors · BiotechnologyRule 506(b)
▶$660.7KraisedNov 2014 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dean GendronDirector
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Robert PotterDirector
- Meg SpencerDirector
- Michael BrunsExecutive Officer
- Daniel ThorneDirector
- Bruno MaruzzoDirector
- David WolfExecutive Officer, Director
- Offering amount
- $660.7K
- Amount sold
- $660.7K
- First sale
- Nov 2014
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Hamilton Thorne raised?
- Hamilton Thorne has disclosed $11.2M raised across 4 rounds.
- Where is Hamilton Thorne headquartered?
- Hamilton Thorne is headquartered in Beverly, US.